Stockreport

Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

Candel Therapeutics, Inc.  (CADL) 
PDF NEEDHAM, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused [Read more]